JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Nine Months Ended 31.December.2021.
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2022 ,inter alia, to consider and approve unaudited financial results for the quarter and nine months ended 31.December.2021. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st December, 2021 JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NANDITA SINGHDesignation :- Company Secretary and Compliance Officer JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window
The trading window was closed on 31 December, 2021 for all the designated persons & immediate relatives of Designated Persons. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Clarification On Price Movement
Clarification on Price Movement JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Clarification sought from Jagsonpal Pharmaceuticals Ltd
The Exchange has sought clarification from Jagsonpal Pharmaceuticals Ltd on December 29, 2021, with reference to Movement in Volume.The reply is awaited. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Under Reg 23(9) Of SEBI (LODR), 2015.
Disclosure under Reg 23(9) of SEBI (LODR), 2015. Jagsonpal Pharmaceuticals Ltd - 507789 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Issuance of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for Intimation of Interim Dividend and Record Date. Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholding for the Period Ended September 30, 2021
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here